4-imidazopyridazin-1-yl-benzamides as BTK inhibitors | Patent Number 10239883

US 10239883 B2
Application Number15668385
Publication NumberUS 20180179212 A1
Pendency1 year, 7 months, 25 days
Filled DateAug 3, 2017
Priority DateJul 19, 2011
Publication DateJun 28, 2018
Expiration DateJul 18, 2031
Inventor/ApplicantsJacobus C.H.M. Wijkmans
Jan Gerard Sterrenburg
Johannes Bernardus Maria Rewinkel
Tjeerd A. Barf
Arthur A. Oubrie
Jacobus C. H. M. Wijkmans
Christiaan Gerardus Johannes Maria Jans
Hans C. A. Raaijmakers
Hans C.A. Raaijmakers
Adrianus Petrus Antonius de Man
ExaminesSHAMEEM, GOLAM M
Art Unit1626
Technology Center1600
Assignments
Merck Sharp & Dohme
Current
Merck Sharp & DohmeMerck & Co. Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.